Grid Therapeutics is a biotech company based on the innovative science first developed by Edward F. Patz, Jr. MD, and his team of scientists at Duke University Medical Center developing the first human-derived targeted immunotherapy for cancer.

Biotechnology

Grid Therapeutics

Grid Therapeutics' headquarters in Durham, NC, United States

Edward F. Patz

Thomas L. Patz

Richard A. Parker

Kevin Schulman

Paolo Paoletti

Gerold Bepler

Michael J. Campa

Dave King

Grid Therapeutics' Leadership Team includes Scott Lyman and 2 others.

About

People

Edward F. Patz

Thomas L. Patz